Hydrogen Research Study
← Back to Research Library
Human clinical evidenceRandomized controlled trialHydrogen water

Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy.

Yang Q, Ji G, Pan R, Zhao Y, Yan P · Molecular and clinical oncology · 2017

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cancer and Supportive Oncology Research
Evidence type Human clinical evidence
Publication type Randomized controlled trial
Hydrogen method Hydrogen water
hydrogen water cancer supportive care study 2017 research summary

The publication “Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy.” is organized in H2HUBB under the research focus hydrogen water cancer supportive care study 2017. The publication is cited as Yang Q, Ji G, Pan R, Zhao Y, Yan P, Molecular and clinical oncology, 2017. This randomized controlled trial examined Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy. The abstract describes Human participants; sample size 80; hydrogen delivered as hydrogen water. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen water cancer supportive care study 2017 overview

The present study was conducted to investigate the protective effect of hydrogen-rich water on the liver function of colorectal cancer (CRC) patients treated with… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Randomized controlled trial. Evidence type: Human clinical evidence. Research model or population: Human participants. Sample size: 80. Randomized: Yes. Blinding: Single-blind. Control status: Unknown.

Delivery method: Hydrogen water.

Reported findings and scientific interpretation

For this hydrogen water cancer supportive care study 2017, the study record reports the following: No detailed finding statement was available for this record. Readers should consult the original publication before drawing conclusions.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The abstract alone may not report all methodological limitations; full-text review is required.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.